TrialClinical drug investigation2021

Efficacy and Safety Results from a Phase 2, Randomized, Double-Blind Study of Enzalutamide Versus Placebo in Advanced Hepatocellular Carcinoma.

Baek-Yeol Ryoo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.